Overview
Tsukasa Murata practices practicing medicine in Kumamoto, Japan.
His clinical expertise encompasses Erythema Multiforme, Schizophrenia, COVID-19, and Severe Acute Respiratory Syndrome (SARS).
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tsukasa Murata
Is Tsukasa Murata a top-rated expert for Erythema Multiforme?
MediFind is an objective health platform that identifies experts based on real-world data. Tsukasa Murata is classified as an Experienced expert for Erythema Multiforme, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tsukasa Murata participate in research or clinical trials?
Yes. Tsukasa Murata has published 11 articles and abstracts on conditions like Erythema Multiforme. You can view a list of Tsukasa Murata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Mr. Murata isExperienced. Learn about COVID-19.
- Erythema MultiformeMr. Murata isExperienced. Learn about Erythema Multiforme.
- SchizophreniaMr. Murata isExperienced. Learn about Schizophrenia.
- Severe Acute Respiratory Syndrome (SARS)